SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is trending as investors react to escalating US-China trade tensions and await insights from upcoming bank earnings and a speech from Fed Chair Powell. Community chatter reflects concerns about market volatility, potential pullbacks, and the impact of Trump's trade policies. Some traders are anticipating a buying opportunity amidst the uncertainty, while others are bracing for a deeper correction.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending amid discussions about market manipulation and potential trade war impacts, with community members debating whether recent price dips represent buying opportunities or signs of a larger correction. Concerns about leveraged positions and insider activity are also circulating, while some analysts maintain a bullish long-term outlook. The digital asset's performance is being closely watched in relation to traditional markets and geopolitical developments.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending due to renewed US-China trade war concerns sparked by China's sanctions on a Korean shipbuilder and the potential for further tariff escalations, creating market volatility. Community discussions revolve around whether these movements are news-driven rather than technical, and whether Trump's actions will reverse the current downturn. Overall sentiment seems mixed, with some expecting a bounce while others anticipate further drawdowns.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst ($BCRX) is trending amid news of its acquisition of Astria Therapeutics ($ATXS) to bolster its HAE portfolio, a move that has sparked mixed reactions. While some investors see long-term growth potential, others express concerns about the acquisition's cost and potential impact on profitability, leading to active discussions about the company's future direction and valuation.

Nova Minerals Ltd. engages in the exploration and development of mineral properties. Its projects include Estelle Gold, RPM, Korbel, Train, Stoney and Studies projects. The company was founded in January 1987 and is headquartered in Melbourne, Australia.

Nova Minerals Limited - ADR

Nova Minerals is trending as discussions revolve around its potential to become a key domestic antimony supplier, especially after the U.S. Department of War awarded funds to Alaska Range Resources (ARR), its subsidiary, to secure the antimony supply chain. The community is focused on the company's unique position with both antimony and gold prospects, viewing it as undervalued compared to other rare earth plays. Some investors express enthusiasm about NVA's long-term growth potential given its Alaskan mining assets.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

$CRML is trending as the U.S. aims to secure rare earth elements and reduce reliance on China, sparking community interest in resource independence and potential government support. Discussions revolve around the company's assets in Greenland and the potential for significant growth in a sector deemed critical for national security. Some traders are pointing to a large move in a related ticker, $CLIK, as a reason for caution.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending due to Shah Capital urging the company's board to pursue a sale, citing underperformance. The community is actively discussing the potential for a buyout, with Shah Capital suggesting a valuation significantly higher than the current market cap. Some are frustrated with management's performance and are looking for a catalyst, such as a partnership or acquisition, to drive the stock price up.

Greenwave Technology Solutions, Inc. is an emerging growth company, which engages in recycling ferrous metal. It also recycles nonferrous metals including aluminum, copper, stainless steel, nickel, brass, titanium, lead, alloys, and mixed metal products. The company was founded on April 26, 2013 and is headquartered in Chesapeake, VA.

Greenwave Technology Solutions Inc

GWAV is trending due to discussions around potential short squeezes and high volatility, with traders actively speculating on entry and exit points. Community members are weighing in on the stock's potential for a significant run-up, while others highlight concerns about past dilutions and reverse splits. The stock's low float and presence in the recycling and critical metals space are also contributing to the heightened interest.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

NVTS is trending due to its partnership with NVIDIA to support the 800 VDC power architecture for next-generation AI factories, sparking discussions around its potential role in the AI infrastructure and data center market. Community members are weighing in on the significance of this collaboration, analyzing short squeeze potential, and the stock's long-term prospects within the semiconductor landscape, particularly for GaN and SiC power devices.

Cyngn, Inc. engages in the development of autonomous driving software that can be deployed on multiple vehicle types in various environments. The company was founded by Kirt McMaster and Steve Kondik in 2013 and is headquartered in Mountain View, CA.

Cyngn Inc

CYN is trending following news of their DriveMod deployment with G&J Pepsi, with investors discussing the potential for a significant run. The community is focused on the low float and potential impact of the Pepsi partnership, while some caution about previous pump-and-dump schemes and dilution. Bullish sentiment revolves around the autonomous tech's potential profitability and comparisons to previous squeezes, while bears express concerns about the company's financials and management.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Upstream Bio (UPB) shares saw an increase in after-hours trading on Friday following the company's presentation of pharmacology modeling data, which showed investigational antibody verekitug as potentially more potent than tezepelumab by targeting the TSLP receptor rather than its ligand.Shares of the company finished at $11.36, down by 1.7%, but rose to $11.41 in after-hours trading with a 0.4% gain.Results from the European Academy of Allergy &amp; Clinical Immunology Congress demonstrated that verekitug produced lasting and thorough blockage of the TSLP/TSLPR complex, which drives critical inflammatory diseases, including severe asthma, as well as COPD and chronic rhinosinusitis with nasal polyps (CRSwNP).The FDA-approved antibody Tezspire (tezepelumab), which targets severe asthma, operates through TSLP ligand inhibition and was developed jointly by AstraZeneca and Amgen.The modeling study used a mechanistic PK/PD approach and incorporated clinical and published data.&nbsp;Simulations predicted that verekitug would lead to a greater reduction in fractional exhaled nitric oxide (FeNO)—a biomarker for airway inflammation—compared to tezepelumab.The company is looking to assess top-line Phase 2 data in CRSwNP later this year, and in severe asthma in the first half of 2026.”Verekitug is the only known monoclonal antibody in clinical development that directly targets the TSLP receptor, offering what the company describes as a more upstream and durable blockade of the inflammatory cascade.The stock moved higher after the release, with investors responding positively to the strengthened differentiation case for verekitug as it advances through multiple Phase 2 trials.&nbsp;These include the Valiant study in severe asthma, the Vibrant trial in CRSwNP, and a planned trial in COPD.Upstream Bio previously reported favorable tolerability, high subcutaneous bioavailability, and a consistent pharmacokinetic profile for verekitug in completed Phase 1 studies.On Stocktwits, retail sentiment was ‘neutral’ amid ‘high’ message volume.Upstream’s stock has declined 30.3% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Portrait of a doctor woman on the background of stock charts. | Image source: Getty Images

Upstream Bio Stock Gets A Boost As New Lung Inflammation Drug Shows Higher Potency

The company is progressing with multiple Phase 2 trials for its investigational treatment targeting severe respiratory diseases.

Equity

Automotive Security Leaders Must Take Immediate Action to Mitigate the Surging Cyber Threats--Upstream Report Reveals Critical Gaps

Automotive Security Leaders Must Take Immediate Action to Mitigate the Surging Cyber Threats--Upstream Report Reveals Critical Gaps Automotive Security Leaders Must Take Immediate Action to Mitigate...

Upstream Bio, Inc. is a clinical-stage biotechnology company, which engages in the development of treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It develops verekitug, the only known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin. The company was founded in April 2021 and is headquartered in Waltham, MA.

Upstream Bio Inc.

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

UPB
Upstream Bio Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest UPB News

UPBUpstream Bio Inc.